Registration Decision RD2020-13, Bacillus amyloliquefaciens strain FZB42 and AmyProtec 42
This decision is consistent with the Proposed Registration Decision PRD2020-04, Bacillus amyloliquefaciens strain FZB42 Technical and AmyProtec 42, whichcontains a detailed evaluation of the information submitted in support of this registration
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Registration Decision RD2020-13, Bacillus amyloliquefaciens strain FZB42 and AmyProtec 42HTMLEnglish publication HTML
-
Registration Decision RD2020-13, Bacillus amyloliquefaciens strain FZB42 and AmyProtec 42HTMLFrench publication HTML
Similar records